Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
72.27
+0.87
+(1.22%)
At close: February 21 at 6:05:00 PM GMT-3
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 14 | 25 | 25 |
| Avg. Estimate | 12.93B | 14.69B | 59.35B | 63.94B |
| Low Estimate | 12.77B | 14.35B | 57.2B | 61.02B |
| High Estimate | 13.35B | 15.03B | 60.57B | 66.64B |
| Year Ago Sales | 12.31B | 14.46B | 56.33B | 59.35B |
| Sales Growth (year/est) | 5.05% | 1.60% | 5.36% | 7.72% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ABBV34.SA | -- | -- | -- | -- |
| S&P 500 | 14.59% | 7.50% | 10.82% | 14.15% |
Related Tickers
AMG.HA Amgen Inc
286.85
+1.34%
D4S.MU Daiichi Sankyo Co Ltd
21.80
-0.59%
BRM.MU Bristol-Myers Squibb Co
52.86
+0.69%
ORNAV.HE Orion Oyj
51.80
0.00%
LLY0.DU Eli Lilly and Co
20.80
+1.96%
NOVNEE.SW Novartis AG
98.04
+1.42%
COPNz.XC
0O59.IL Sanofi
104.04
+0.64%
SNW.F Sanofi
103.16
+0.19%
NOTA.F Novartis AG
100.00
-0.50%